2024年10月21日 · According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational treatment reduced vision loss and protected key structures in the eye essential for vision.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

2024年8月28日 · The American Academy of Ophthalmology indicates that consumers who may see the eye color-changing drops advertised and used on TikTok or elsewhere online should be advised that they are not FDA approved.

2024年12月26日 · As 2024 comes to a close, we here at Ophthalmology Times and the greater Eye Care Network would like to thank you–the reader. Throughout the year, we have had the privilege of covering a wide range of topics in ophthalmology. As always, stay tuned to see highlights from the year from all other Eye Care Brands on Ophthalmology Times. Now, we take a look back at some of the highlights of 2024 ...

2024年10月1日 · Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL), TECNIS Odyssey, in the US. The TECNIS Odyssey IOL is a new full vision range IOL, built on the TECNIS platform from Johnson & Johnson, which according to the company provides two times better contrast in low lighting than PanOptix. 1 Peter Menziuso, company group chairman, Vision, Johnson & Johnson ...

2024年10月18日 · Thomas Aaberg Jr, MD sat down to discuss previous presentations by Neurotech at EURETINA and Retina Society as well as upcoming presentations on NT-501 at this year's American Academy of Ophthalmology meeting held in Chicago, Illinois.

2024年10月19日 · Key Takeaways Long-term valacyclovir treatment reduces new or worsening eye disease in HZO by 26% and decreases pain duration and medication use. The ZEDS study supports extending antiviral treatment to a year, beyond the standard 7-10 days, for better outcomes. Prevention through the Shingrix vaccine is emphasized, with low vaccination rates despite increasing shingles incidence in those over ...

2024年11月13日 · Reviewed by Mark Packer, MD; and Eric Donnenfeld, MD In June 2024, a canalicular gel device (Lacrifill, Nordic Pharma) was introduced to the US market, and a recent study has shown it to be a safe, well-tolerated, and effective treatment for dry eye. 1 This device offers a new option for managing a condition that affects millions of patients. A study, led by first author Mark Packer, MD ...

2024年12月26日 · Key Takeaways Gene therapy using adeno-associated vectors shows promise in delivering DNA to treat retinal diseases, but long-term safety remains uncertain. The port delivery system (PDS) offers continuous ranibizumab delivery, reducing treatment burden, but faces challenges like surgical precision and endophthalmitis risk. Encapsulated cell therapy (ECT) combines gene therapy and drug ...

2024年11月6日 · The Valeda Light Delivery System is for the treatment of patients with dry age-related macular degeneration (AMD).